精神分裂症中单基因拷贝数变异的特征分析
该研究基于瑞典4913例精神分裂症患者与6188名对照的外显子组测序数据,整合XHMM与ExomeDepth两种CNV检测方法,并用定量PCR与NanoString验证变异。结果显示病例组全部罕见CNV及单基因CNV均显著增多,并在电压门控钙通道基因集中验证到4个外显子区单基因缺失,均见于病例组。
要点
- 病例组全部罕见缺失与重复CNV均显著多于对照,单基因CNV亦然。
- 电压门控钙通道基因集中验证到4个外显子区单基因缺失,均见于病例组。
- 外显子组测序用于CNV检测的效用尚未被充分发挥。
核心结论
- 结果提示单基因CNV可能对精神分裂症有贡献,且单基因CNV应纳入基于其他变异类型的基因聚焦研究。
研究设计与样本
- 研究对来自瑞典的4913例精神分裂症病例与6188名对照进行外显子组测序并生成CNV。
- 整合XHMM与ExomeDepth两种CNV检测方法以扩展单基因CNV集合。
- 采用定量聚合酶链反应与NanoString两种方法验证变异。
主要发现
- 病例组全部罕见CNV显著多于对照:缺失p = .0004,重复p = .0006。
- 病例组单基因CNV显著多于对照:缺失p = .04,重复p = .03。
- 整合多种方法扩展的CNV集在21个既往涉及精神分裂症的基因集中的11个显示缺失负荷显著,跨这些基因集全部基因p = .008,但无检验通过校正。
- 在电压门控钙通道基因集中验证到4个外显子区单基因缺失见于病例组、对照为零(p = .039),且均由外显子组测序识别。
关键数值与推荐
- 病例组全部罕见缺失CNV p = .0004,重复CNV p = .0006。
- 病例组单基因缺失CNV p = .04,单基因重复CNV p = .03。
- 21个基因集中11个显示缺失负荷显著,跨全部基因p = .008,无检验通过校正。
- 电压门控钙通道基因集4个外显子区单基因缺失见于病例组、对照0个,p = .039。
临床怎么用
- 对精神分裂症遗传风险评估与基因聚焦研究,可将单基因CNV纳入变异筛查范围。
- 外显子组测序数据可用于CNV检测,但需多种检测方法整合与实验验证以提高可靠性。
局限性
- 基因集负荷分析无检验通过多重校正。
- 单基因CNV验证集中于电压门控钙通道基因集,其他基因集结果有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic studies of schizophrenia have implicated numerous risk loci including several copy number variants (CNVs) of large effect and hundreds of loci of small effect. In only a few cases has a specific gene been clearly identified. Rare CNVs affecting a single gene offer a potential avenue to discovering schizophrenia risk genes. METHODS: CNVs were generated from exome sequencing of 4913 schizophrenia cases and 6188 control subjects from Sweden. We integrated two CNV calling methods (XHMM and ExomeDepth) to expand our set of single-gene CNVs and leveraged two different approaches for validating these variants (quantitative polymerase chain reaction and NanoString). RESULTS: We found a significant excess of all rare CNVs (deletions: p = .0004, duplications: p = .0006) and single-gene CNVs (deletions: p = .04, duplications: p = .03) in schizophrenia cases compared with control subjects. An expanded set of CNVs generated from integrating multiple approaches showed a significant burden of deletions in 11 of 21 gene sets previously implicated in schizophrenia and across all genes in those sets (p = .008), although no tests survived correction. We performed an extensive validation of all deletions in the significant set of voltage-gated calcium channels among CNVs called from both exome sequencing and genotyping arrays. In total, 4 exonic, single-gene deletions were validated in schizophrenia cases and none in control subjects (p = .039), of which all were identified by exome sequencing. CONCLUSIONS: These results point to the potential contribution of single-gene CNVs to schizophrenia, indicate that the utility of exome sequencing for CNV calling has yet to be maximized, and note that single-gene CNVs should be included in gene-focused studies using other classes of variation.
引用
- Szatkiewicz JP, Fromer M, Nonneman RJ, et al. Characterization of Single Gene Copy Number Variants in Schizophrenia. Biol Psychiatry. 2019. PMID: 31767120. doi:10.1016/j.biopsych.2019.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。